268 related articles for article (PubMed ID: 26044584)
1. ABO Blood Group as a Model for Platelet Glycan Modification in Arterial Thrombosis.
Zhong M; Zhang H; Reilly JP; Chrisitie JD; Ishihara M; Kumagai T; Azadi P; Reilly MP
Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1570-8. PubMed ID: 26044584
[TBL] [Abstract][Full Text] [Related]
2. Expression of ABH antigens on platelets.
Curtis BR; Aster RH
Blood; 2006 Jan; 107(2):842; author reply 842-3. PubMed ID: 16401826
[No Abstract] [Full Text] [Related]
3. Thrombosis and thrombolysis: platelet membrane glycoproteins.
Skinner MP
Heart Lung Circ; 2007 Jun; 16(3):176-9. PubMed ID: 17446123
[TBL] [Abstract][Full Text] [Related]
4. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?
Jenkins PV; O'Donnell JS
Transfusion; 2006 Oct; 46(10):1836-44. PubMed ID: 17002642
[TBL] [Abstract][Full Text] [Related]
5. ABO blood group and thrombotic vascular disease.
Franchini M; Mannucci PM
Thromb Haemost; 2014 Dec; 112(6):1103-9. PubMed ID: 25187297
[TBL] [Abstract][Full Text] [Related]
6. Platelets as Biomarkers of Coronary Artery Disease.
Pasalic L; Wang SS; Chen VM
Semin Thromb Hemost; 2016 Apr; 42(3):223-33. PubMed ID: 26926585
[TBL] [Abstract][Full Text] [Related]
7. Determinants of ABH expression on human blood platelets.
Cooling LL; Kelly K; Barton J; Hwang D; Koerner TA; Olson JD
Blood; 2005 Apr; 105(8):3356-64. PubMed ID: 15613545
[TBL] [Abstract][Full Text] [Related]
8. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes.
Spiel AO; Gilbert JC; Jilma B
Circulation; 2008 Mar; 117(11):1449-59. PubMed ID: 18347221
[TBL] [Abstract][Full Text] [Related]
9. ABO blood groups and thrombosis: a causal association, but is there value in screening?
Clark P; Wu O
Future Cardiol; 2011 Mar; 7(2):191-201. PubMed ID: 21453026
[TBL] [Abstract][Full Text] [Related]
10. Blood platelet biochemistry.
Broos K; De Meyer SF; Feys HB; Vanhoorelbeke K; Deckmyn H
Thromb Res; 2012 Mar; 129(3):245-9. PubMed ID: 22119499
[TBL] [Abstract][Full Text] [Related]
11. Platelet expression of transforming growth factor beta 1 is enhanced and associated with cardiovascular prognosis in patients with acute coronary syndrome.
Rath D; Chatterjee M; Müller I; Müller K; Böckmann C; Droppa M; Stimpfle F; Karathanos A; Borst O; Seizer P; Langer H; Schwab M; Gawaz M; Geisler T
Atherosclerosis; 2014 Dec; 237(2):754-9. PubMed ID: 25463116
[TBL] [Abstract][Full Text] [Related]
12. Relative Risks of Thrombosis and Bleeding in Different ABO Blood Groups.
Franchini M; Lippi G
Semin Thromb Hemost; 2016 Mar; 42(2):112-7. PubMed ID: 26716497
[TBL] [Abstract][Full Text] [Related]
13. The Role of ABO Blood Type in Thrombosis Scoring Systems.
Franchini M; Marano G; Vaglio S; Catalano L; Pupella S; Liumbruno GM
Semin Thromb Hemost; 2017 Jul; 43(5):525-529. PubMed ID: 28297729
[TBL] [Abstract][Full Text] [Related]
14. Binding of oxidized low-density lipoprotein on circulating platelets is increased in patients with acute coronary syndromes and induces platelet adhesion to vascular wall in vivo--brief report.
Stellos K; Sauter R; Fahrleitner M; Grimm J; Stakos D; Emschermann F; Panagiota V; Gnerlich S; Perk A; Schönberger T; Bigalke B; Langer HF; Gawaz M
Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):2017-20. PubMed ID: 22701021
[TBL] [Abstract][Full Text] [Related]
15. Platelet transfusion refractoriness responding preferentially to single donor aphaeresis platelets compatible for both ABO and HLA.
McVey M; Cserti-Gazdewich CM
Transfus Med; 2010 Oct; 20(5):346-53. PubMed ID: 20492602
[TBL] [Abstract][Full Text] [Related]
16. Recent therapeutic approaches to platelet activation in coronary artery disease.
Tousoulis D; Paroutoglou IP; Papageorgiou N; Charakida M; Stefanadis C
Pharmacol Ther; 2010 Aug; 127(2):108-20. PubMed ID: 20546778
[TBL] [Abstract][Full Text] [Related]
17. Platelets and primary haemostasis.
Clemetson KJ
Thromb Res; 2012 Mar; 129(3):220-4. PubMed ID: 22178577
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical Effect of Nonphysiological Shear Stress on Platelets and von Willebrand Factor.
Chen Z; Mondal NK; Ding J; Koenig SC; Slaughter MS; Wu ZJ
Artif Organs; 2016 Jul; 40(7):659-68. PubMed ID: 26582038
[TBL] [Abstract][Full Text] [Related]
19. ABO incompatible platelets: risks versus benefit.
Dunbar NM; Ornstein DL; Dumont LJ
Curr Opin Hematol; 2012 Nov; 19(6):475-9. PubMed ID: 22914587
[TBL] [Abstract][Full Text] [Related]
20. Advances in platelet function testing assessing bleeding complications in patients with coronary artery disease.
Rollini F; Tello-Montoliu A; Angiolillo DJ
Platelets; 2012; 23(7):537-51. PubMed ID: 22812566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
